{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-113524","form_type":"8-K","ticker":"SANA","cik":"0001770121","company_name":"Sana Biotechnology, Inc.","filed_at":"2024-10-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.544723+00:00","generated_at":"2026-05-30T18:10:36.371325+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Sana Biotechnology CFO Nathan Hardy resigns; CEO Harr named acting PFO, Susan Wyrick acting CFO","bullets":["CFO Nathan Hardy resigned effective Oct 4, 2024; acting appointments made same day.","CEO Steven D. Harr appointed acting Principal Financial Officer; no compensation change.","Susan Wyrick appointed Acting CFO, Treasurer, and PAO; receives $5k/month extra, $25k bonus, 20,000 RSUs.","Wyrick previously SVP Finance; former VP Controller at Juno Therapeutics prior to Celgene acquisition."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-113524","json":"https://secwatch.observer/filing/0000950170-24-113524.json","markdown":"https://secwatch.observer/filing/0000950170-24-113524.md","text":"https://secwatch.observer/filing/0000950170-24-113524.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770121/000095017024113524/0000950170-24-113524-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770121/000095017024113524/sana-20241004.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T18:10:36.371325+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"78425c0b2a","claim":"Nathan Hardy resigned as Executive Vice President and Chief Financial Officer, Treasurer, Principal Financial Officer, Principal Accounting Officer at Sana Biotechnology, Inc..","evidence_excerpt":"Nathan Hardy’s resignation as Executive Vice President and Chief Financial Officer, Treasurer, Principal Financial Officer (“PFO”), and Principal Accounting Officer (“PAO”)","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770121/000095017024113524/0000950170-24-113524-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer, Treasurer, Principal Financial Officer, Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"cc5188fadf","claim":"Susan Wyrick was appointed as Acting Chief Financial Officer, Treasurer, and Principal Accounting Officer at Sana Biotechnology, Inc..","evidence_excerpt":"Susan Wyrick, the Company’s Senior Vice President, Finance and Accounting, was appointed to serve as Acting Chief Financial Officer, Treasurer, and PAO","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770121/000095017024113524/0000950170-24-113524-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Acting Chief Financial Officer, Treasurer, and Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"cd90582ea7","claim":"Steven D. Harr was appointed as acting Principal Financial Officer at Sana Biotechnology, Inc..","evidence_excerpt":"Steven D. Harr, M.D., the Company’s President and Chief Executive Officer, was appointed to serve as acting PFO in addition to his role as President and Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770121/000095017024113524/0000950170-24-113524-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"acting Principal Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}